Inhibition of CD47 signaling has been proved to be to induce Sirpα-dependent phagocytosis, thereby enhancing the phagocytosis activity of innate cells against cancer cells and targeting the innate immune regulatory system [65, 66]. The gene discussed is CD47; the disease is cancer.